Pricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Stockholders' equity

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥34.5B
P/E ratio
10.7x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Dec 31, 202518,684+7.66%
Dec 31, 202417,354+10.71%
Dec 31, 202315,676+9.75%
Dec 31, 202214,283+77.90%
Dec 31, 20218,029+112.19%
Dec 31, 20203,784+0.80%
Dec 31, 20193,754+18.95%
Dec 31, 20183,156+29.47%
Dec 31, 20172,437+28.51%
Dec 31, 20161,897+19.30%
Dec 31, 20151,590+37.07%
Dec 31, 20141,160+31.10%
Dec 31, 2013885

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat